Allergan and Pfizer have announced that they are calling off their proposed merger. In December 2015, the two companies announced the proposed merger at a total enterprise value of approximately $160 billion, which would bring Pfizer back into a therapeutic area of focus of dermatology. It also would have created the world’s largest drug company [...]